Cited by 887Immunotherapy and Immune ResponsesAluminum toxicity and tolerance in plants and animalsImmune responses and vaccinations

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

Towards an understanding of the adjuvant action of aluminium

Open access

Marrack, Philippa, McKee, Amy S., Munks, Michael W.·2009·Nature Reviews Immunology

DOI 10.1038/nri2510PMC PMC3147301

Open this paper in CoChat — free account

Abstract

The efficacy of vaccines depends on the presence of an adjuvant in conjunction with the antigen. Of these adjuvants, the ones that contain aluminium, which were first discovered empirically in 1926, are currently the most widely used. However, a detailed understanding of their mechanism of action has only started to be revealed. In this Timeline article, we briefly describe the initial discovery of aluminium adjuvants and discuss historically important advances. We also summarize recent progress in the field and discuss their implications and the remaining questions on how these adjuvants work.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nri2510

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.
Mosmann, T. R., Cherwinski, H. M., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,553
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization
Hornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658 · cited 1×
“Related reports have shown that other particulate materials, such as silica, asbestos and MSU crystals, also act through the NLRP3 inflammasome to produce IL-1&beta”
How dying cells alert the immune system to danger
Kono, H., & Rock, K. L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2215 · Cited by 1,737
Molecular identification of a danger signal that alerts the immune system to dying cells
Shi, Y., Evans, J. E., & Rock, K. L. (2003) · Nature · doi:10.1038/nature01991 · Cited by 1,684
Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
Eisenbarth, S. C., Colegio, O. R., O’Connor, W., Sutterwala, F. S., & Flavell, R. A. (2008) · Nature · doi:10.1038/nature06939 · Cited by 1,542
Toll-like receptors control activation of adaptive immune responses
Schnare, M., Barton, G. M., Czopik, A. K., Takeda, K., Akira, S., & Medzhitov, R. M. (2001) · Nature Immunology · doi:10.1038/ni712 · Cited by 1,364
Disruption of the murine IL-4 gene blocks Th2 cytokine responses
Köpf, M., Gros, G. S. L., Bachmann, M. F., Lamers, M. C., Bluethmann, H., & Köhler, G. (1993) · Nature · doi:10.1038/362245a0 · Cited by 1,202
Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells
Kool, M., Soullié, T., van Nimwegen, M., Willart, M. A. M., Muskens, F., Jung, S., Hoogsteden, H. C., Hammad, H., & Lambrecht, B. N. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071087 · Cited by 1,014

Flagged first, then by citations

Show all 63 references

Research works printed but not linked: 1

Ramon, G. Sur le pouvoir floculant et sur les proprietes immunisantes d'une toxine diphtherique rendue anatoxique. C. R. Hebd. Seances Acad. Sci. 177, 1338–1340 (1923).

Sorted by citations

Items 301–400 of 885

The Effect of Different Adjuvants on Immune Parameters and Protection following Vaccination of Sheep with a Larval-Specific Antigen of the Gastrointestinal Nematode, Haemonchus contortus
Piedrafita, D. M., Preston, S., Kemp, J. M., de Veer, M., Sherrard, J., Kraska, T., Elhay, M. J., & Meeusen, E. N. T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078357 · Cited by 32
Fatty Acid-Mimetic Micelles for Dual Delivery of Antigens and Imidazoquinoline Adjuvants
Sevimli, S., Knight, F. C., Gilchuk, P., Joyce, S., & Wilson, J. T. (2016) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00408 · Cited by 32
Efficacy and limitations of SARS-CoV-2 vaccines - A systematic review
Azeem, M., Cancemi, P., Mukhtar, F., Marino, S., Peri, E., Prima, G. D., & De, V. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123610 · Cited by 33
Aluminum and Neurodegenerative Diseases
Bondy, S. C., & Campbell, A. (2017) · Advances in neurotoxicology · doi:10.1016/bs.ant.2017.07.008 · Cited by 31
Distinct single-component adjuvants steer human DC-mediated T-cell polarization via Toll-like receptor signaling toward a potent antiviral immune response
Roßmann, L., Bagola, K., Stephen, T., Gerards, A.-L., Walber, B., Ullrich, A., Schülke, S., Kamp, C., Spreitzer, I., Hasan, M., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2103651118 · Cited by 31
Clinical vaccine development for H5N1 influenza
Clegg, C. H., Rininger, J. A., & Baldwin, S. L. (2013) · Expert Review of Vaccines · doi:10.1586/14760584.2013.811178 · Cited by 31
Development of safe, effective and immunogenic vaccine candidate for diarrheagenic Escherichia coli main pathotypes in a mouse model
Gohar, A., Abdeltawab, N. F., Fahmy, A., & Amin, M. A. (2016) · BMC Research Notes · doi:10.1186/s13104-016-1891-z · Cited by 31
GPRC6A mediates Alum-induced Nlrp3 inflammasome activation but limits Th2 type antibody responses
Quandt, D., Rothe, K., Baerwald, C., & Rossol, M. (2015) · Scientific Reports · doi:10.1038/srep16719 · Cited by 32
Immunomodulation of TH2 biased immunity with mucosal administration of nanoemulsion adjuvant
Bielinska, A. U., O’Konek, J. J., Janczak, K. W., & Baker, J. R. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.06.043 · Cited by 31
Evolution of Adjuvants Across the Centuries
Garçon, N., & Friede, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00006-7 · Cited by 31
Structure-based design of chimeric antigens for multivalent protein vaccines
Hollingshead, S., Jongerius, I., Exley, R. M., Johnson, S., Lea, S. M., & Tang, C. M. (2018) · Nature Communications · doi:10.1038/s41467-018-03146-7 · Cited by 31
Immunomodulatory Peptides as Vaccine Adjuvants and Antimicrobial Agents
Hemmati, S., Saeidikia, Z., Seradj, H., & Mohagheghzadeh, A. (2024) · Pharmaceuticals · doi:10.3390/ph17020201 · Cited by 31
The CTA1-DD adjuvant strongly potentiates follicular dendritic cell function and germinal center formation, which results in improved neonatal immunization
Schussek, S., Bernasconi, V., Mattsson, J., Wenzel, U. A., Strömberg, A., Gribonika, I., Schön, K., & Lycke, N. Y. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-0253-2 · Cited by 26
Chimeric SV40 virus-like particles induce specific cytotoxicity and protective immunity against influenza A virus without the need of adjuvants
Kawano, M., Morikawa, K., Suda, T., Ohno, N., Matsushita, S., Akatsuka, T., Handa, H., & Matsui, M. (2013) · Virology · doi:10.1016/j.virol.2013.10.010 · Cited by 30
Evaluation of the immunoprophylactic potential of a killed vaccine candidate in combination with different adjuvants against murine visceral leishmaniasis
Thakur, A., Kaur, H., & Kaur, S. (2014) · Parasitology International · doi:10.1016/j.parint.2014.10.003 · Cited by 30
Amino-Modified Polymer Nanoparticles as Adjuvants to Activate the Complement System and to Improve Vaccine Efficacy in Vivo
Pan, Y., Qi, Y., Shao, N., Tadle, A. C., & Huang, Y. (2019) · Biomacromolecules · doi:10.1021/acs.biomac.9b00887 · Cited by 30
ASIA syndrome, calcinosis cutis and chronic kidney disease following silicone injections. A case-based review
Barilaro, G., Testa, C. S., Cacciani, A., Donato, G., Dimko, M., & Mariotti, A. (2016) · Immunologic Research · doi:10.1007/s12026-016-8871-1 · Cited by 29
Self healing hydrogels: A new paradigm immunoadjuvant for delivering peptide vaccine
Gupta, D., Gangwar, A., Jyoti, K., Jyothi, V. G. S. S., Sodhi, R. K., Mehra, N. K., Singh, S. B., & Madan, J. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2020.111171 · Cited by 29
High‐ and low‐molecular‐weight chitosan act as adjuvants during single‐dose influenza A virus protein vaccination through distinct mechanisms
Lampe, A. T., Farris, E., Brown, D. M., & Pannier, A. K. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27647 · Cited by 30
From vaccine practice to vaccine science: the contribution of human immunology to the prevention of infectious disease
Mortellaro, A., & Ricciardi‐Castagnoli, P. (2011) · Immunology and Cell Biology · doi:10.1038/icb.2010.152 · Cited by 29
Adyuvantes inmunológicos. Determinantes en el balance eficacia-toxicidad de las vacunas contemporáneas
Batista-Duharte, A., Lastre, M., & Pérez, O. (2013) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2012.11.012 · Cited by 31
Comparison of adjuvants to optimize influenza neutralizing antibody responses
Rudicell, R. S., Garinot, M., Kanekiyo, M., Kamp, H. D., Swanson, K. A., Chou, T.-H. W., Dai, S., Bedel, O., Simard, D., Gillespie, R. A., et al. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.08.030 · Cited by 29
Periodic Table of Immunomodulatory Elements and Derived Two‐Dimensional Biomaterials
Rafieerad, A., Saleth, L. R., Khanahmadi, S., Amiri, A., Alagarsamy, K. N., & Dhingra, S. (2025) · Advanced Science · doi:10.1002/advs.202406324 · Cited by 29
Vaccines against human diarrheal pathogens
Böhles, N., Böhles, N., Busch, K., Busch, K., Hensel, M., & Hensel, M. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.29241 · Cited by 28
CpG incorporated DNA microparticles for elevated immune stimulation for antigen presenting cells
Jung, H., Kim, D., Kang, Y. Y., Kim, H., Lee, J. B., & Mok, H. (2018) · RSC Advances · doi:10.1039/c7ra13293j · Cited by 28
Tailored Silica Nanomaterials for Immunotherapy
Gu, L. (2018) · ACS Central Science · doi:10.1021/acscentsci.8b00181 · Cited by 28
Development of a hollow mesoporous silica nanoparticles vaccine to protect against house dust mite induced allergic inflammation
Peng, X., Liang, Y., Yin, Y., Liao, H., & Li, L. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.07.047 · Cited by 28
Influenza Vaccines: Current Status, Adjuvant Strategies, and Efficacy
Mokalla, V. R., Gundarapu, S., Kaushik, R. S., Rajput, M., & Tummala, H. (2025) · Vaccines · doi:10.3390/vaccines13090962 · Cited by 29
Selective Elevation of Circulating CCL2/MCP1 Levels in Patients with Longstanding Post-vaccinal Macrophagic Myofasciitis and ASIA
Cadusseau, J., Ragunathan, N., Surénaud, M., Hüe, S., Authier, F., & Gherardi, R. K. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113206660287 · Cited by 28
The adjuvant aluminum fate – Metabolic tale based on the basics of chemistry and biochemistry
Ćirović, A., Ćirović, A., Nikolić, D., Ivanovski, A., & Ivanovski, P. (2021) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2021.126822 · Cited by 27
Archaeosomes and Gas Vesicles as Tools for Vaccine Development
Adamiak, N., Krawczyk, K. T., Locht, C., & Kowalewicz‐Kulbat, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.746235 · Cited by 27
Use of Phage Display technology in development of canine visceral leishmaniasis vaccine using synthetic peptide trapped in sphingomyelin/cholesterol liposomes
Toledo-Machado, C. M., Bueno, L. L., Menezes‐Souza, D., Machado‐de‐Ávila, R. A., Nguyen, C., Granier, C., Bartholomeu, D. C., Chávez-Olórtegui, C., & Fujiwara, R. T. (2015) · Parasites & Vectors · doi:10.1186/s13071-015-0747-z · Cited by 27
Aluminum doped carbon nanodots as potent adjuvants on the mammalian macrophages
Ayaz, F., Alaş, M. Ö., Oğuz, M., & Genç, R. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-04701-1 · Cited by 27
Formulation of aluminum hydroxide adjuvant with TLR agonists poly(I:C) and CpG enhances the magnitude and avidity of the humoral immune response
Lu, F., Mosley, Y. C., Carmichael, B. E., Brown, D. D., & HogenEsch, H. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.02.033 · Cited by 26
Nanovaccines for Advancing Long-Lasting Immunity against Infectious Diseases
Gao, X., Wang, X., Li, S., Rahman, M. S. U., Xu, S., & Liu, Y. (2023) · ACS Nano · doi:10.1021/acsnano.3c07741 · Cited by 27
Responses to multiple injections with alum alone compared to injections with alum adsorbed to proteins in mice
Wang, X., Yao, X., Wan, Y., Wang, B., Xu, J., & Wen, Y. (2012) · Immunology Letters · doi:10.1016/j.imlet.2012.11.005 · Cited by 26
Characterization of the UK anthrax vaccine and human immunogenicity
Modi, T., Gervais, D., SMITH, S. K., Miller, J. A., Subramaniam, S., Thalassinos, K., & Shepherd, A. J. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1799668 · Cited by 26
Immunogenicity Studies of Plant-Produced SARS-CoV-2 Receptor Binding Domain-Based Subunit Vaccine Candidate with Different Adjuvant Formulations
Siriwattananon, K., Manopwisedjaroen, S., Shanmugaraj, B., Prompetchara, E., Ketloy, C., Buranapraditkun, S., Tharakhet, K., Kaewpang, P., Ruxrungtham, K., Thitithanyanont, A., et al. (2021) · Vaccines · doi:10.3390/vaccines9070744 · Cited by 26
Regulation of CD4 T‐cell receptor diversity by vaccine adjuvants
Baumgartner, C., & Malherbe, L. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03265.x · Cited by 33
Al adjuvants can be tracked in viable cells by lumogallion staining
Mile, I., Svensson, A., Darabi, A., Mold, M. J., Siesjö, P., & Eriksson, H. (2015) · Journal of Immunological Methods · doi:10.1016/j.jim.2015.04.008 · Cited by 26
Analysis of Aluminium in Rat Following Administration of Allergen Immunotherapy Using Either Aluminium or Microcrystalline-Tyrosine-Based Adjuvants
McDougall, S. A., Heath, M. D., Kramer, M. F., & Skinner, M. A. (2016) · Bioanalysis · doi:10.4155/bio.16.10 · Cited by 26
GAD-alum immunotherapy in type 1 diabetes expands bifunctional Th1/Th2 autoreactive CD4 T cells
Arif, S., Gomez-Touriño, I. M., Kamra, Y., Pujol‐Autonell, I., Hanton, E., Tree, T. I. M., Melandri, D., Hull, C., Wherrett, D. K., Beam, C. A., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05130-7 · Cited by 26
Porcine Dendritic Cells as an In Vitro Model to Assess the Immunological Behaviour of Streptococcus suis Subunit Vaccine Formulations and the Polarizing Effect of Adjuvants
Martelet, L., Lacouture, S., Goyette-Desjardins, G., Beauchamp, G., Surprenant, C., Gottschalk, M. G., & Segura, M. (2017) · Pathogens · doi:10.3390/pathogens6010013 · Cited by 25
Engineering biodegradable guanidyl-decorated PEG-PCL nanoparticles as robust exogenous activators of DCs and antigen cross-presentation
Li, P., Song, H., Zhang, H., Yang, P., Zhang, C., Huang, P., Kong, D., & Wang, W. (2017) · Nanoscale · doi:10.1039/c7nr04470d · Cited by 25
Stabilization of tetanus toxoid formulation containing aluminium hydroxide adjuvant against freeze-thawing
Solanki, V. A., Jain, N. K., & Roy, I. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.022 · Cited by 25
Developing vaccines for an aging population
BLACK, S. B., Gregorio, E. D., & Rappuoli, R. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa0722 · Cited by 27
Type II NKT cells facilitate Alum-sensing and humoral immunity
Shah, H. B., Devera, T. S., Rampuria, P., Lang, G. A., & Lang, M. L. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0412177 · Cited by 25
Studies on the protective efficacy of freeze thawed promastigote antigen of Leishmania donovani along with various adjuvants against visceral leishmaniasis infection in mice
Thakur, A., Kaur, H., & Kaur, S. (2015) · Immunobiology · doi:10.1016/j.imbio.2015.05.014 · Cited by 25
Si-doping increases the adjuvant activity of hydroxyapatite nanorods
Wang, X., Ihara, S., Li, X., Ito, A., Sogo, Y., Watanabe, Y., Tsuji, N. M., & Yamazaki, A. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.11.026 · Cited by 25
The structure of Yersinia pestis Caf1 polymer in free and adjuvant bound states
Soliakov, A., Harris, J. R., Watkinson, A., & Lakey, J. H. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.05.074 · Cited by 25
Induction of decreased fecundity by tetanus toxoid hyper-immunization in C57BL/6 mice depends on the applied adjuvant
Zivkovic, I. P., Petrušić, V., Stojanović, M., Inić‐Kanada, A., Stojićević, I., & Dimitrijević, L. (2011) · Innate Immunity · doi:10.1177/1753425911407361 · Cited by 24
pH-Controlled Release of Antigens Using Mesoporous Silica Nanoparticles Delivery System for Developing a Fish Oral Vaccine
Zhang, W., Zhu, C., Xiao, F., Liu, X., Xie, A., Chen, F., Dong, P., Lin, P., Zheng, C., Zhang, H., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.644396 · Cited by 24
The Coming of Age of Nucleic Acid Vaccines during COVID-19
Rando, H. M., Lordan, R., Kolla, L., Sell, E., Lee, A. J., Wellhausen, N., Naik, A. S., Kamil, J. P., Gitter, A., Greene, C. S., et al. (2023) · mSystems · doi:10.1128/msystems.00928-22 · Cited by 30
Prospects for the Use of Metal-Based Nanoparticles as Adjuvants for Local Cancer Immunotherapy
Николаевна, Н. И., Tomasello, B., Attanasio, F., & Pleshkan, V. V. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051346 · Cited by 24
Progress towards Adjuvant Development: Focus on Antiviral Therapy
Brai, A., Poggialini, F., Pasqualini, C., Trivisani, C. I., Vagaggini, C., & Dreassi, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119225 · Cited by 25
A polysaccharide isolated from Agaricus blazei Murill (ABP-AW1) as a potential Th1 immunity-stimulating adjuvant
Cui, L., Sun, Y., XU, H., Xu, H., CONG, H., & Liu, J. (2013) · Oncology Letters · doi:10.3892/ol.2013.1484 · Cited by 24
Efficacy comparison of adjuvants in PcrV vaccine against Pseudomonas aeruginosa pneumonia
Hamaoka, S., Naito, Y., Katoh, H., Shimizu, M., Kinoshita, M., Akiyama, K., Kainuma, A., Moriyama, K., Ishii, K. J., & Sawa, T. (2017) · Microbiology and Immunology · doi:10.1111/1348-0421.12467 · Cited by 24
Recent Advances in Particulate Adjuvants for Cancer Vaccination
Song, C., Li, F., Wang, S., Wang, J., Wei, W., & Ma, G. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201900115 · Cited by 24
The role of innate immunity in asthma development and protection: Lessons from the environment
Pivniouk, V. I., Gimenes-Júnior, J. A., Honeker, L. K., & Vercelli, D. (2019) · Clinical & Experimental Allergy · doi:10.1111/cea.13508 · Cited by 24
Cationic Lipid/DNA Complex-Adjuvanted Influenza A Virus Vaccination Induces Robust Cross-Protective Immunity
Hong, D. K., Chang, S., Botham, C. M., Giffon, T. D., Fairman, J., & Lewis, D. B. (2010) · Journal of Virology · doi:10.1128/jvi.00769-10 · Cited by 24
Adjuvants: friends in vaccine formulations against infectious diseases
Manríquez, G. G. G., & Tuero, I. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1934354 · Cited by 24
Nasal alum-adjuvanted vaccine promotes IL-33 release from alveolar epithelial cells that elicits IgA production via type 2 immune responses
Sasaki, E., Asanuma, H., Momose, H., Furuhata, K., Mizukami, T., & Hamaguchi, I. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009890 · Cited by 23
Antigenicity and immunogenicity of a novel chimeric peptide antigen based on the P. vivax circumsporozoite protein
Céspedes, N., Arévalo‐Herrera, M., Felger, I., Reed, S., Kajava, A. V., Corradin, G., & Herrera, S. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.05.082 · Cited by 23
Engineered biomaterials for development of nucleic acid vaccines
Yang, H. J., Li, Y., Jin, S., Xu, J., Wang, P. C., Liang, X., & Zhang, X. (2015) · Biomaterials Research · doi:10.1186/s40824-014-0025-8 · Cited by 23
Association of chitosan and aluminium as a new adjuvant strategy for improved vaccination
Lebre, F., Bento, D., Ribeiro, J. B., Colaço, M., Borchard, G., de Lima, M. C. P., & Borges, O. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.05.028 · Cited by 23
Effects of immunomodulators on the response induced by vaccines against autoimmune diseases
Marciani, D. J. (2017) · Autoimmunity · doi:10.1080/08916934.2017.1373766 · Cited by 23
Alternative delivery of a thermostable inactivated polio vaccine
Kraan, H., Ploemen, I., van de Wijdeven, G. G. P., Que, I., Löwik, C. W. G. M., Kersten, G. F. A., & Amorij, J. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.03.011 · Cited by 22
Immune-mediated myelitis following hepatitis B vaccination
Stübgen, J. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.03.008 · Cited by 22
Novel Viral Vectored Vaccines for the Prevention of Influenza
Lambe, T. (2012) · Molecular Medicine · doi:10.2119/molmed.2012.00147 · Cited by 22
Small GTPase—A Key Role in Host Cell for Coronavirus Infection and a Potential Target for Coronavirus Vaccine Adjuvant Discovery
Hou, W., Wang, S., Wu, H., Xue, L., Wang, B., Wang, S., & Wang, H. (2022) · Viruses · doi:10.3390/v14092044 · Cited by 23
Multi-omics for COVID-19: driving development of therapeutics and vaccines
Guo, M., Xiong, M., Peng, J., Guan, T., Su, H., Huang, Y., Yang, C., Li, Y., Boraschi, D., Pillaiyar, T., et al. (2023) · National Science Review · doi:10.1093/nsr/nwad161 · Cited by 24
Metal chelation therapy in rheumathoid arthritis: a case report
Bamonti, F., Fulgenzi, A., Novembrino, C., & Ferrero, M. E. (2011) · BioMetals · doi:10.1007/s10534-011-9467-9 · Cited by 22
Induction of APS after TTd Hyper-Immunization has a Different Outcome in BALB/c and C57BL/6 Mice
Zivkovic, I. P., Stojanović, M., Petrušić, V., Inić‐Kanada, A., & Dimitrijević, L. (2010) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2010.00922.x · Cited by 22
Potential therapeutic targets in the process of nucleic acid recognition: opportunities and challenges
He, S., Mao, X., Sun, H., Shirakawa, T., Zhang, H., & Wang, X. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.10.013 · Cited by 22
Evaluation of the protective immune response induced in mice by immunization with Schistosoma mansoni schistosomula tegument (Smteg) in association with CpG-ODN
de Melo, T. T., de Araújo, J. M., Romano, I. C. S., Alves, C. C., Araújo, N., & Fonseca, C. T. (2012) · Microbes and Infection · doi:10.1016/j.micinf.2012.10.007 · Cited by 22
Robust Immunity and Heterologous Protection against Influenza in Mice Elicited by a Novel Recombinant NP-M2e Fusion Protein Expressed in E. coli
Wang, W., Huang, B., Jiang, T., Wang, X., Qi, X., Gao, Y., Tan, W., & Ruan, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052488 · Cited by 22
The role of adjuvants in vaccines for seasonal and pandemic influenza
Brown, L. E. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.09.024 · Cited by 22
New adjuvanted vaccines in pregnancy: what is known about their safety?
Herberts, C. A., Melgert, B. N., van der Laan, J. W., & Faas, M. M. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.133 · Cited by 22
Antigen-Specific Immunotherapeutic Vaccine for Experimental Autoimmune Myasthenia Gravis
Luo, J., & Lindstrom, J. M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401392 · Cited by 22
Adjuvant effect of liposome-encapsulated natural phosphodiester CpG-DNA
Kim, D., Kwon, S., Ahn, C.-S., Lee, Y., Choi, S., Park, J., Kwon, H.-Y., & Kwon, H. (2011) · BMB Reports · doi:10.5483/bmbrep.2011.44.11.758 · Cited by 22
Recombinant subunit vaccines protect guinea pigs from lethal Ebola virus challenge
Lehrer, A. T., Wong, T. A. S., Lieberman, M. M., Johns, L. M., Medina, L. O., Feldmann, F., Feldmann, H., & Marzi, A. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.06.035 · Cited by 22
Meeting vaccine formulation challenges in an emergency setting: Towards the development of accessible vaccines
Peletta, A., Lemoine, C., Courant, T., Collin, N., & Borchard, G. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106699 · Cited by 21
Design and Evaluation of Synthetic Delivery Formulations for Peptide-Based Cancer Vaccines
Song, K., & Pun, S. H. (2024) · BME Frontiers · doi:10.34133/bmef.0038 · Cited by 20
Towards functional antibody-based vaccines to prevent pre-erythrocytic malaria infection
Sack, B. K., Kappe, S. H. I., & Sather, D. N. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1295853 · Cited by 19
An overview of FDA-approved vaccines & their innovators
Griesenauer, R. H., & Kinch, M. S. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1383159 · Cited by 23
A TLR4-derived non-cytotoxic, self-assembling peptide functions as a vaccine adjuvant in mice
Tandon, A., Pathak, M., Harioudh, M. K., Ahmad, S., Sayeed, M., Afshan, T., Siddiqi, M. I., Mitra, K., Bhattacharya, S. M., & Ghosh, J. K. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002768 · Cited by 21
Developing a pH-sensitive Al(OH) 3 layer-mediated UCNP@Al(OH) 3 /Au nanohybrid for photothermal therapy and fluorescence imaging in vivo
Chen, J., Zhang, D., Zou, Y., Wang, Z., Hao, M., Zheng, M., Xue, X., Pan, X., Lu, Y., Wang, J., et al. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb02213e · Cited by 21
Design, production and immunomodulatory potency of a novel allergen bioparticle
Gomord, V., Stordeur, V., Fitchette, A., Fixman, E. D., Tropper, G., Garnier, L., Desgagnés, R., Viel, S., Couillard, J., Beauverger, G., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242867 · Cited by 21
Recent advances in self-adjuvanting glycoconjugate vaccines
Manabe, Y., Chang, T., & Fukase, K. (2020) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2020.11.006 · Cited by 21
Importance of Cry Proteins in Biotechnology: Initially a Bioinsecticide, Now a Vaccine Adjuvant
González‐Vázquez, M. C., Vela-Sanchez, R. A., Rojas-Ruíz, N. E., & Carabarín‐Lima, A. (2021) · Life · doi:10.3390/life11100999 · Cited by 22
Adjuvants and lymphoma risk as part of the ASIA spectrum
Butnaru, D., & Shoenfeld, Y. (2015) · Immunologic Research · doi:10.1007/s12026-014-8622-0 · Cited by 21
SV40 virus-like particles as an effective delivery system and its application to a vaccine carrier
Kawano, M., Matsui, M., & Handa, H. (2013) · Expert Review of Vaccines · doi:10.1586/erv.12.149 · Cited by 21
The challenge of assessing infant vaccine responses in resource-poor settings
Flanagan, K. L., Burl, S., Lohman-Payne, B. L., & Plebanski, M. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.41 · Cited by 21
Opinion: Making Inactivated and Subunit-Based Vaccines Work
Chua, B. Y. L., Sekiya, T., & Jackson, D. C. (2018) · Viral Immunology · doi:10.1089/vim.2017.0146 · Cited by 23
Photo-induced anti-inflammatory activities of chloro substituted subphthalocyanines on the mammalian macrophage in vitro
Ayaz, F., Ugur, N., Ocakoğlu, K., & Ince, M. (2019) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2019.02.002 · Cited by 21
Alum as an adjuvant for nanoparticle based vaccines: A case study with a hybrid nanoparticle-based nicotine vaccine
Hu, Y. Y., Smith, D., Zhao, Z., Harmon, T. M., Pentel, P. R., Ehrich, M. F., & Zhang, C. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.102023 · Cited by 19
Peptides as Versatile Regulators in Cancer Immunotherapy: Recent Advances, Challenges, and Future Prospects
Lei, Y., Liu, J., Bai, Y., Zheng, C., & Wang, D. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17010046 · Cited by 20
Vaccine adjuvant activity of a TLR4-activating synthetic glycolipid by promoting autophagy
Chou, Y.-J., Lin, C.-C., Dzhagalov, I. L., Chen, N.-J., Lin, C., Lin, C.-C., Chen, S.-T., Chen, K.-H., & Fu, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-65422-1 · Cited by 22
Nitric Oxide Production and Fc Receptor-Mediated Phagocytosis as Functional Readouts of Macrophage Activity upon Stimulation with Inactivated Poultry Vaccines In Vitro
van den Biggelaar, R. H. G. A., van Eden, W., Rutten, V. P. M. G., & Jansen, C. A. (2020) · Vaccines · doi:10.3390/vaccines8020332 · Cited by 20
The sixth revolution in pediatric vaccinology: immunoengineering and delivery systems
Soni, D., Bobbala, S. K. R., Li, S., Scott, E. A., & Dowling, D. J. (2020) · Pediatric Research · doi:10.1038/s41390-020-01112-y · Cited by 21

Authors: Marrack, P., McKee, A. S., & Munks, M. W.
Affiliations: Howard Hughes Medical Institute (US)
Corresponding author: Marrack, Philippa
ORCID: Marrack, Philippa
McKee, Amy S.
Munks, Michael W.
Venue: Nature Reviews Immunology
Publisher: Springer Science and Business Media LLC
Published: 2009-04
Volume: 9
Issue: 4
Pages: 287-293
ISSN: 1474-1733 (ISSN-L)
1474-1741
DOI: 10.1038/nri2510
PMC: PMC3147301
OpenAlex: W1990954596
Cited by: 887
References: 63
Citations by year: 2026: 44 · 2025: 47 · 2024: 57 · 2023: 47 · 2022: 41 · 2021: 67 · 2020: 50 · 2019: 45 · 2018: 49 · 2017: 65 · 2016: 56 · 2015: 72 · 2014: 44 · 2013: 64 · 2012: 49
FWCI: 3.59
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Immunology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: Howard Hughes Medical Institute
National Institute of Allergy and Infectious Diseases (P01AI022295, R37AI018785)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Life Sciences › Agricultural and Biological Sciences › Plant Science › Aluminum toxicity and tolerance in plants and animals
Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
Keywords: alum adjuvant, aluminum salts, vaccine adjuvants, adjuvant mechanisms, vaccine efficacy, immunogenicity
MeSH terms: NLR Family, Pyrin Domain-Containing 3 Protein, Adjuvants, Immunologic, Adsorption, Aluminum, Animals, Antibody Formation, Antigen-Presenting Cells, Antigens, Carrier Proteins, Cytoskeletal Proteins, Humans, Immunity, Cellular, Immunity, Innate, Aluminum Compounds, Models, Immunological, Caspase 1, Apoptosis Regulatory Proteins, Mice, CARD Signaling Adaptor Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Towards an understanding of the adjuvant action of aluminium

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks